Unrivaled Brands UNRV stock analysis & what is next for UNRV stock

Clearmind Medicine Secures Exclusive Global Rights to Breakthrough Psychedelic Compounds for PTSD Treatment | Psychedelic Invest

Vancouver, Canada, May 07, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and

May 8, 2024

Sickle cell disease: A global call to action

Reducing the burden of Sickle Cell Disease (SCD) requires substantial financial and political commitment to improving data-collection, diagnosis, treatment and training – doing so will

July 12, 2023

Vita 34 returns to growth path in 2023 – Biotech Investments

EQS-News: Vita 34 AG / Key word(s): Annual Results Vita 34 returns to growth path in 2023 30.04.2024 / 22:51 CET/CEST The issuer is solely

May 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.